US arm launches pump packs for Adapalene Gel USP, 0.1% (OTC)
Glenmark Therapeutics Inc., USA has launched Adapalene Gel USP, 0.1% (OTC) in new pump packs — a pump-style dispensing format instead of a tube.
- Pack sizes
- 15 g and 45 g pumps
- Sales channels
- Amazon and Walmart.com in the US
- Market size - Differin Gel, 0.1% (OTC) annual sales
- $45.8 million for the 52-week period ended September 5, 2026
What was announced
Glenmark Therapeutics Inc., USA has launched Adapalene Gel USP, 0.1% (OTC) in new pump packs. OTC means over-the-counter, i.e. sold without a prescription. The company says its product can be compared to the active ingredient of Differin Gel, 0.1%. The change here is the pack format: the same product is now offered in a pump rather than a tube.
Pack sizes and where it is being sold
- Adapalene Gel USP, 0.1% - 15 g Pump on Amazon
- Adapalene Gel USP, 0.1% - 45 g Pump on Amazon
- Adapalene Gel USP, 0.1% - 15 g Pump on Walmart.com
- Adapalene Gel USP, 0.1% - 45 g Pump on Walmart.com
The market size it points to
The update cites Nielsen syndicated data for the latest 52-week period ending September 5, 2026: the Differin Gel, 0.1% (OTC) market achieved annual sales of approximately $45.8 million. That figure describes the market, which includes the brand and all available therapeutic equivalents. It is not Glenmark's own revenue.
What management said
Marc Kikuchi, President & Business Head, North America, said the introduction of Adapalene Gel USP, 0.1% (OTC) in the new pump pack enhances consumer experience by offering a convenient and easy-to-use dispensing option, while further strengthening the company's growing U.S. dermatology portfolio. He added that the launch reflects the company's commitment to delivering high-quality and affordable healthcare solutions.
Footnotes attached to the release
- The product is only marketed for the indications listed in Glenmark's approved drug facts label.
- The market data note says Glenmark's product is only approved for, and will only be marketed for, the indications in its approved label, which may differ from the approved RLD indications.
- The product is not manufactured or distributed by Galderma Laboratories, L.P. and/or Galderma Holding S.A., the distributor of DIFFERIN Gel and owner of the registered trademark DIFFERIN.
How to read it
This is a commercial or product update: an additional pack format in an existing US over-the-counter dermatology line, already being retailed through Amazon and Walmart.com. Such announcements show the company widening its product offering in a market it operates in; the eventual contribution depends on how the product sells. Nothing here changes the company's share capital, ownership or borrowings.
Also from Glenmark Pharmaceuticals
Nomura retained buy call on Glenmark Pharma with stock up about 4.8%, raising target price to 3,750 rupees from 3,300 rupees
7 Oct 2026
More numbers
- Differin Gel, 0.1% (OTC) market annual sales cited (52-week period)$45.8 million
- Product strength0.1%
- Pack size - pump on Amazon15 g
- Pack size - pump on Amazon45 g
- Period covered by the cited market data52-week
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.